• Fibrobiologics walks the unconventional financing path

  • May 15 2024
  • Length: 18 mins
  • Podcast

Fibrobiologics walks the unconventional financing path

Listen for free

View show details

  • Summary

  • A non-traditional route for financing has been the path to success for Fibrobiologics Inc. In the newest BioWorld Insider podcast, CEO Pete O’Heeron offers insight into the company’s unusual path to a Nasdaq listing in January. SPACs, reverse mergers and traditional IPOs weren’t attractive enough for Fibrobiologics’ management or board, so they decided to go public through a direct listing with no banks as underwriters. It took about seven months to get the company ready for its listing, an around-the-clock effort that O’Heeron said was worth the effort. “We couldn’t be more happy with the outcome,” he said.
    Show more Show less
Show more Show less

What listeners say about Fibrobiologics walks the unconventional financing path

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available